Position in ROIV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$55,922,959
+$11,807,302 QoQ
Shares Held
1,580,191
-0.8% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
5.91%
of 13F equity value
Holder Rank
#55
of 494 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PENN DAVIS MCFARLAND INC holds $55,922,959 across 1 Biotechnology name. ROIV ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
1,580,191 | $55,922,959 |
All Filings in ROIV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,922,959 | 1,580,191 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $44,115,657 | 1,592,623 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $40,324,871 | 1,858,289 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $28,173,391 | 1,862,088 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $19,064,692 | 1,691,632 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $17,225,970 | 1,707,232 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $19,507,977 | 1,649,026 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $18,835,518 | 1,632,194 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $17,249,383 | 1,631,919 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $17,286,917 | 1,640,125 | Shares | Sole | 2024-04-25 | |
| No filing history on record for this holder in this stock. | ||||||